The AT and EZ were quantified using multiple INCB024360 in vitro reaction monitoring (MRM) of the

precursor ion and the related product ion using the internal standard method with peak area ratios. AT and IS were monitored using positive ionization mode while EZ was monitored using negative ionization mode. The mass transitions used for AT, EZ and the IS were m/z 559.57 → 440.4, 408.43 → 271.25 and 182.12 → 164.02, respectively (dwell time 0.08 s). Stock solutions of AT, EZ and the IS (100 μg mL−1) were prepared daily in methanol. The AT and EZ standard solutions were serially diluted with methanol to reach a concentration of 10–200 ng mL−1. 200 μL of the serially diluted solutions were added to 1.8 mL of drug-free plasma (originating from six different sources) to obtain concentrations of 0.1, 0.3, 0.5, 1, 3, 5, 10, and 20 ng mL−1. The IS was diluted with methanol to 100 ng mL−1. A calibration graph was derived from the peak area ratios of AT and EZ to the IS using a linear regression. Quality controls were prepared daily in human plasma (obtained from the holding DNA Damage inhibitor company for biological products and vaccines, VACSERA), for low (0.2 ng mL−1 AT and EZ), medium (4 ng mL−1 AT and EZ), and high (15 ng mL−1 AT and EZ) concentrations to evaluate the precision and accuracy of the assay method. Venous blood samples were collected in heparinized tubes and, within 30 min of collection, were centrifuged at 3500 rpm (Centurion

Scientific LTD., West Sussex, UK) for 10 min at 4 °C. Plasma was transferred to clean cryovials and stored at −20 °C until analysis. All samples and reagents were brought to room temperature on the day of analysis. Aliquots (500 μL) of volunteer samples, blank plasma, calibration samples and quality control (QC) solutions were transferred to 10-mL centrifuge tubes containing 200 μL of IS in methanol (100 ng mL−1) and 100 μL of phosphate buffer (0.025 mol L−1, pH 6.8). After vortex mixing for 1 min, 5 mL of tert-butyl Tryptophan synthase methyl ether were added to each tube. All tubes

were vortex-mixed for 2 min, and centrifuged at 3000 g for 5 min at room temperature. Then 4.5 mL of the upper organic layer were transferred to other labelled tubes and evaporated to dryness under vacuum in Eppendorf concentrator (Eppendorf 5301, Germany) at about 45 °C. The residue was reconstituted with 100 μL of mobile phase consisting of 0.1% formic acid in water and acetonitrile in a ratio of 95:5, vortex-mixed for 30 s and transferred to UPLC microvial where 10 μL of this solution were injected into the column. The method described above was validated with regard to linearity, sensitivity, accuracy, precision, specificity, percent recovery, dilution integrity, and stability according to accepted guidelines.14 and 15 The calibration of AT and EZ was performed using a blank sample, a zero sample and eight calibration standards prepared in drug-free plasma originating from six different sources.